Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 521680

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

Thomas T. Aparicio , Michel Ducreux , Roger Faroux , Emilie Barbier , Sylvain Manfredi et al.
European Journal of Cancer, 2018, 98, pp.1-9. ⟨10.1016/j.ejca.2018.03.031⟩
Article dans une revue hal-01983308v1

PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

J-B. Bachet , O. Lucidarme , C.B. Levache , E. Maillard , J.L. Raoul et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.505P, ⟨10.1093/annonc/mdx393.031⟩
Communication dans un congrès hal-01632415v1

The epidemiology of Budd–Chiari syndrome in France

Isabelle Ollivier-Hourmand , Manon Allaire , Nathalie Goutte , Rémy Morello , Carine Chagneau-Derrode et al.
Digestive and Liver Disease, 2018, 50 (9), pp.931-937. ⟨10.1016/j.dld.2018.04.004⟩
Article dans une revue hal-02057088v1

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

J.B. Bachet , O. Lucidarme , C.B. Levache , E. Barbier , J.L. Raoul et al.
European Journal of Cancer, 2018, 104, pp.108-116. ⟨10.1016/j.ejca.2018.09.006⟩
Article dans une revue hal-01960176v1

Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22)

M. Karoui , A. Rullier , C. Mariette , E. Maillard , A. Bardier et al.
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.476O, ⟨10.1093/annonc/mdx393.003⟩
Communication dans un congrès hal-01632311v1